Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
1 Eating disorders are complex mental illnesses that may require comprehensive treatment
GLP-1 receptor agonists bind to GLP-1 receptors in the pancreas, stimulating insulin secretion when blood glucose levels are elevated whilst simultaneously suppressing glucagon release
You'll get to self-schedule it during the onboarding process
In a study comparing tirzepatide and semaglutide, tirzepatide reduced HbA1c by 2.01% to 2.30%, depending on the dose, while semaglutide reduced it by 1.86% in 40 weeks 13
Tirzepatide While semaglutide has a half-life of approximately 7 days supporting once-weekly dosing, tirzepatide (a dual GLP-1 and GIP receptor agonist) has a similar half-life of about 5 days
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
